• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nrx Pharmaceuticals Inc (NQ: NRXP )

    1.370 -0.060 (-4.20%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nrx Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    NRx is Eligible for $324 Million in Development and Sales Milestones, Plus Double-Digit Royalties Upon Approval and Commercialization of NRX-101: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Viz Release
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    5 Biotech stocks tapping into unmet mental health treatment needs
    Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments. 
    Via MarketBeat
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Earnings Preview: NRX Pharmaceuticals
    Via Benzinga
    Earnings Preview: NRX Pharmaceuticals
    Via Benzinga
    Recap: NRX Pharmaceuticals Q1 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Earnings Preview: NRX Pharmaceuticals
    Via Benzinga
    NRx Pharma Raises Doubt To Continue As Going Concern
    Via Benzinga
    Earnings Preview For NRX Pharmaceuticals
    Via Benzinga
    Monitoring Board Recommends NRx Pharma's Suicidal Bipolar Depression Study To Continue Enrollment
    Via Benzinga
    Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
    No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet. 
    Via MarketBeat
    Topics Bonds
    Exposures Debt Markets
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Featured in Virtual Coverage of Dawson James Small Cap Growth Conference
    Via Investor Brand Network
    Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Investors to Contact the Firm
    From Kaskela Law LLC
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Earnings Scheduled For August 14, 2023
    Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Earnings Scheduled For March 30, 2023
    Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.